Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen.
Citation
Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen 2013, 10 (6):601 Personalized MedicineJournal
Personalized MedicineDOI
10.2217/pme.13.60Additional Links
http://www.futuremedicine.com/doi/abs/10.2217/pme.13.60Type
ArticleLanguage
enISSN
1741-05411744-828X
ae974a485f413a2113503eed53cd6c53
10.2217/pme.13.60